TRPV2 and viral infectious disease: Knocking out TRPV2 or inhibiting its channel activity in myeloid cells inhibits viral infection and protects mice from Herpes Simplex Virus type 1 (HSV-1) and Vesicular Stomatitis Virus (VSV) [39].